Auditory verbal hallucination and suicide: a systematic review.

Psychiatry ResMay 20, 2026 (epub)
Clinical ResearchPsychiatry

Sirui Lu, Sherry Kit Wa Chan, Christy Lai Ming Hui

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined the relationship between auditory verbal hallucinations (AVH) and various dimensions of suicidality across clinical populations. Out of 1981 articles screened, 29 met the inclusion criteria. The review found significant associations between AVH and suicidal ideation, attempts, and non-suicidal self-injury, with the individual's appraisal of the voices being a key factor.

Key findings

  • Significant associations were found between AVH and suicidal ideation, attempts, and non-suicidal self-injury.
  • The individual's appraisal of the voices was consistently linked to suicidality.
  • The role of AVH in the transition from suicidal ideation to attempts remains inconclusive.

Why it matters

Understanding the relationship between AVH and suicidality can help clinicians assess suicide risk more effectively. Evaluating cognitive appraisals related to AVH may provide insights into patients' mental health and inform intervention strategies.

Source

PubMed · PMID 42202618

Published in Psychiatry Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.